Medical Automation Market Size, Share, Growth, Trends | Report 2022-2030
The global medical automation market was surpassed at USD 40.3 billion in 2021 and is expected to hit around USD 88.2 billion by 2030, growing at a CAGR of 9.1% from 2022 to 2030.
This is attributed to the rapid technological advancements in lab and pharmacy automation, as well as diagnostic and monitoring automation, which are generating global demand for healthcare automation. Increased government involvement is expected to drive the global healthcare automation market over the forecast period.
Healthcare automation provides cutting-edge solutions in hospital pharmacy automation, logistics and transport, and material handling applications. Healthcare automation is being invested in by labs and research facilities all around the world to simplify various processes and increase overall work productivity. This automation is helping research institutes leverage overall productivity in healthcare facilities, improve experimental data quality, and reduce lab process cycle times, as a result, increasing automation adoption by pharmacies, labs, and research centers is expected to drive market growth over the forecast period.
Furthermore, the rising prevalence of chronic illnesses, as well as the increasing implementation of automated diagnostic and therapeutic equipment, are driving market expansion. According to the World Health Organization (WHO), chronic illnesses are one of the main causes of death in the world, with cancer, stroke, heart disease, diabetes, and respiratory disorders accounting for roughly 60% of all fatalities. Furthermore, according to NCBI, by 2030, around 40.5% of the US population is expected to have one or more cardiovascular disorders, expanding the customer base for this industry.
Market players adopt strategies such as collaborations, launches, and mergers & acquisitions to strengthen their industry position. For instance, in June 2022, GE Healthcare collaborated with Medtronic to accelerate global access to personalized care by offering an advanced patient monitoring system on the CARESCAPE platform. This collaboration enabled GE Healthcare to advance patient care, improve decision-making, boost healthcare system efficiency, and link caregivers & their patients within an ecosystem
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 40.3 billion |
| Revenue Forecast by 2030 | USD 88.2 billion |
| Growth rate from 2022 to 2030 | CAGR of 9.1% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Application, end-use, region |
| Companies Covered |
Accuray, Inc.; Tecan Group Ltd.; Medtronic Plc.; Swisslog Holding AG; GE Healthcare; Intuitive Surgical, Inc.; Stryker Corporation; Siemens AG; Koninklijke Philips N.V.; Danaher Corporation; Zimmer Biomet |
Application Insights
Based on the application type, the market is fragmented into imaging automation, therapeutic automation, laboratory and pharmacy automation, medical software, informatics, and logistics automation markets. Therapeutic automation held the largest share of the market in 2021, accounting for more than 54% of total market revenue.
Imaging Automation Market
The market is supported by the growth of the intraoperative imaging segment, which made up more than 64% of the overall imaging automation market in 2021. This is due to the increase in the usage of less invasive treatments as well as technological advancements. For instance, Philips announced major updates to its Zenition mobile C-arm platform in June 2020.
Therapeutic Automation Market
The market is supported by the expansion of the surgical automation segment, which is growing at a compound annual growth rate of over 9%. This is a combination of both technical developments and an increase in the strategic initiatives taken by the companies. For instance, organizations' strategic initiatives, such as the BPCI, CJR, and advanced value-based reimbursement models, have given manufacturers the chance to offer supplementary goods and services that will successfully broaden the continuum of care.
Medical Software, Informatics, And Logistics Automation Market
The overall market is expanding at the compound annual growth rate of 9.04%, supported by the growth of the logistics automation segment over the forecast period. Furthermore, the rising need for automated material handling solutions across healthcare manufacturing sectors and rapid urbanization expansion is driving the market expansion.
End-Use Insights
The end-use segment is dominated by hospitals and diagnostic centers with over 51.0% share in 2021. The dominance is due to the rising usage of automated equipment in diagnostics, treatment, and laboratories.
The rise of this industry is being driven by automation in pharmacies and hospitals, particularly in tier 2 and tier 3 cities of the growing economies of Asia Pacific, including India. For example, institutions like Apollo and Fortis in India are working to offer computerized healthcare services that are functioning in tier 2 and tier 3 towns.
The research laboratories & institutes segment is anticipated to grow at a positive compound annual growth rate of over 9%. This is attributed to the presence of government-assisted agencies and acceptance of the new products launched into the market.
Regional Insights
North America dominated the industry in 2021 owing to high R&D investments, product launches, and government initiatives. Furthermore, the growth is attributed to the presence of a well-established healthcare infrastructure, which has increased the use of laboratory automation in the region. In addition, the supportive reimbursement framework and the local presence of major players in this region are also boosting the penetration of novel solutions in the market.
The Europe medical automation market is expected to expand at a CAGR of 9.30% in the forecast period of 2022 to 2030. The rising demand for technology-driven systems, the presence of major players, and the presence of well-established and developed healthcare infrastructure are expected to contribute to the region's market growth.
In addition, the presence of government agencies, such as the Medicines and Healthcare Products Regulatory Agency, is critical in certifying pharmacy automation systems and other devices with European standards, which is expected to give growth opportunities in the coming years for this regional market.
Furthermore, the markets in Asia Pacific are expected to exhibit the fastest compound annual growth rate (CAGR) over the forecast period owing to the developing healthcare sector, increasing cases of chronic diseases, and growing government and corporate investment in the healthcare sector, which are the major growth factors in this region.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Automation Market
5.1. COVID-19 Landscape: Medical Automation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Automation Market, By Application
8.1. Medical Automation Market, by Application, 2022-2030
8.1.1. Imaging Automation Market
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Therapeutic Automation Market
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Laboratory and Pharmacy Automation Market
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Medical Software, Informatics, and Logistics Automation Market
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Medical Automation Market, By End-Use
9.1. Medical Automation Market, by End-Use, 2022-2030
9.1.1. Hospitals & Diagnostic Centers
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Research Laboratories & Institutes
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Pharmacies
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Others (Home/Ambulatory Care Settings, etc.)
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Medical Automation Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Application (2017-2030)
10.1.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Application (2017-2030)
10.1.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Application (2017-2030)
10.1.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Application (2017-2030)
10.2.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Application (2017-2030)
10.2.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Application (2017-2030)
10.2.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Application (2017-2030)
10.2.5.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Application (2017-2030)
10.2.6.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Application (2017-2030)
10.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Application (2017-2030)
10.3.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Application (2017-2030)
10.3.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Application (2017-2030)
10.3.5.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Application (2017-2030)
10.3.6.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Application (2017-2030)
10.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Application (2017-2030)
10.4.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Application (2017-2030)
10.4.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Application (2017-2030)
10.4.5.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Application (2017-2030)
10.4.6.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Application (2017-2030)
10.5.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Application (2017-2030)
10.5.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Application (2017-2030)
10.5.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
Chapter 11. Company Profiles
11.1. Accuray, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Tecan Group Ltd.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Medtronic Plc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Swisslog Holding AG
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. GE Healthcare
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Intuitive Surgical, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Stryker Corporation
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Siemens AG
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Koninklijke Philips N.V.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Danaher Corporation
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers